These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Characteristics and incidence of metastatic bone tumors in malignant epithelial neoplasms]. Napolitano A; Pulcini M Ann Ital Chir; 1977; 48(5-6):419-34. PubMed ID: 612242 [No Abstract] [Full Text] [Related]
24. [Clinical features of pathologically confirmed metastatic bone tumors--a report of 390 cases]. Xu DL; Zhang XT; Wang GH; Li FB; Hu JY Ai Zheng; 2005 Nov; 24(11):1404-7. PubMed ID: 16552972 [TBL] [Abstract][Full Text] [Related]
25. Clinical features of metastatic bone disease and risk of skeletal morbidity. Coleman RE Clin Cancer Res; 2006 Oct; 12(20 Pt 2):6243s-6249s. PubMed ID: 17062708 [TBL] [Abstract][Full Text] [Related]
26. [Value of fine-needle puncture in the diagnosis of cancer]. Pedio G Arch Geschwulstforsch; 1984; 54(1):69-75. PubMed ID: 6703863 [TBL] [Abstract][Full Text] [Related]
27. Abnormal bone remodeling process is due to an imbalance in the receptor activator of nuclear factor-kappaB ligand (RANKL)/osteoprotegerin (OPG) axis in patients with solid tumors metastatic to the skeleton. Mountzios G; Dimopoulos MA; Bamias A; Papadopoulos G; Kastritis E; Syrigos K; Pavlakis G; Terpos E Acta Oncol; 2007; 46(2):221-9. PubMed ID: 17453373 [TBL] [Abstract][Full Text] [Related]
28. Metastatic skeletal disease distal to the elbow and knee. Leeson MC; Makley JT; Carter JR Clin Orthop Relat Res; 1986 May; (206):94-9. PubMed ID: 3708998 [TBL] [Abstract][Full Text] [Related]
29. [Cytological studies in patients with skeletal metastases]. Tomory I; Vincze E; Riskó T; Eckhardt S Z Orthop Ihre Grenzgeb; 1968 Oct; 105(3):37-46. PubMed ID: 4247838 [No Abstract] [Full Text] [Related]
30. Bone metastases in breast cancer, prostate cancer and myeloma. Paterson AH Bone; 1987; 8 Suppl 1():S17-22. PubMed ID: 3318889 [TBL] [Abstract][Full Text] [Related]
31. Neoplasms metastatic to the thyroid gland. Czech JM; Lichtor TR; Carney JA; van Heerden JA Surg Gynecol Obstet; 1982 Oct; 155(4):503-5. PubMed ID: 7123465 [TBL] [Abstract][Full Text] [Related]
32. SnapShot: Bone Metastasis. Ell B; Kang Y Cell; 2012 Oct; 151(3):690-690.e1. PubMed ID: 23101634 [No Abstract] [Full Text] [Related]
33. Comparison of serum bone resorption markers in the diagnosis of skeletal metastasis. Koizumi M; Takahashi S; Ogata E Anticancer Res; 2003; 23(5b):4095-9. PubMed ID: 14666607 [TBL] [Abstract][Full Text] [Related]
34. Strontium-89 therapy for painful osseous metastatic prostate and breast cancer. Hansen DV; Holmes ER; Catton G; Thorne DA; Chadwick DH; Schmutz DA Am Fam Physician; 1993 Jun; 47(8):1795-800. PubMed ID: 7684554 [TBL] [Abstract][Full Text] [Related]
35. The relative use of eight collagenous and noncollagenous markers for diagnosis of skeletal metastases in breast, prostate, or lung cancer patients. Leeming DJ; Koizumi M; Byrjalsen I; Li B; Qvist P; Tankó LB Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):32-8. PubMed ID: 16434583 [TBL] [Abstract][Full Text] [Related]
36. Bisphosphonates for cancer patients: why, how, and when? Body JJ; Mancini I Support Care Cancer; 2002 Jul; 10(5):399-407. PubMed ID: 12136223 [TBL] [Abstract][Full Text] [Related]
37. Hypercalcemia and bone resorption in malignancy. Walls J; Bundred N; Howell A Clin Orthop Relat Res; 1995 Mar; (312):51-63. PubMed ID: 7634618 [TBL] [Abstract][Full Text] [Related]
38. Local effects of malignancy on bone. Brown SA; Clines GA; Guise TA Curr Opin Endocrinol Diabetes Obes; 2007 Dec; 14(6):436-41. PubMed ID: 17982348 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of the patient with carcinoma of unknown origin metastatic to bone. Rougraff BT Clin Orthop Relat Res; 2003 Oct; (415 Suppl):S105-9. PubMed ID: 14600599 [TBL] [Abstract][Full Text] [Related]
40. Toward new horizons: the future of bisphosphonate therapy. Lipton A Oncologist; 2004; 9 Suppl 4():38-47. PubMed ID: 15459428 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]